If it's in the News, it's in our Polls. Public opinion polling since 2003.

 

Fighting the Flu: 46% Plan to Get Flu Shot this Year

Thursday, November 09, 2006

Flu season is around the corner and 46% of respondents to a recent Rasmussen Reports survey on this seasonal topic say they plan to receive the flu vaccine this year. Forty-seven percent (47%) will take their chances by skipping the shot. Common symptoms of influenza (“the flu”) include fever, headache, fatigue, congestion and stomach ailments. Each year, the flu affects as much as 20% of the United States population.

Percentages of those who plan to receive the vaccine clearly correlate with age. Less than one-third of respondents (31%) ages 18-29 plan to get the flu shot while nearly three-quarters of individuals (74%) age 65 and older say the same.

OR

Become a member and get full access to all articles and polls starting at $4.95/month.

Rasmussen Reports is a media company specializing in the collection, publication and distribution of public opinion information.

We conduct public opinion polls on a variety of topics to inform our audience on events in the news and other topics of interest. To ensure editorial control and independence, we pay for the polls ourselves and generate revenue through the sale of subscriptions, sponsorships, and advertising. Nightly polling on politics, business and lifestyle topics provides the content to update the Rasmussen Reports web site many times each day. If it's in the news, it's in our polls. Additionally, the data drives a daily update newsletter and various media outlets across the country.

Some information, including the Rasmussen Reports daily Presidential Tracking Poll and commentaries are available for free to the general public. Subscriptions are available for $4.95 a month or 34.95 a year that provide subscribers with exclusive access to more than 20 stories per week on upcoming elections, consumer confidence, and issues that affect us all. For those who are really into the numbers, Platinum Members can review demographic crosstabs and a full history of our data.

To learn more about our methodology, click here.